
the Zileuton Study Group
Advertisement
Articles by the Zileuton Study Group
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
2
ATTR-CM Incidence, Prevalence Rose Sharply in the US
3
FDA Approves Palbociclib for HR+, HER2+ Breast Cancer Maintenance
4
First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention
5